Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials

Journal of Clinical Microbiology
Sabine Rüsch-GerdesSalman Siddiqi

Abstract

The BACTEC MGIT 960 system, a fully automated, nonradiometric, noninvasive system for detection and drug susceptibility testing of mycobacteria, was evaluated for the ability to test susceptibilities to second-line drugs. In this study, which was carried out in three phases (phase I, mostly susceptible strains; phase II, mostly resistant strains; phase III, final testing of the optimal drug concentrations found in phases I and II), we established the critical concentrations for seven drugs to be tested in the BACTEC MGIT 960 system compared to the BACTEC 460TB system. The critical concentrations for the seven drugs used in the MGIT 960 system are as follows: amikacin, 1.0 microg/ml; capreomycin, 2.5 microg/ml; ethionamide, 5.0 microg/ml; protionamide, 2.5 microg/ml; ofloxacin, 2.0 microg/ml; rifabutin, 0.5 microg/ml; linezolid, 1.0 microg/ml. Our results demonstrate that the BACTEC MGIT 960 system is an accurate method for rapid testing of the susceptibilities of Mycobacterium tuberculosis to second-line drugs.

References

Apr 1, 1993·Journal of Clinical Microbiology·F C TenoverR C Good
May 1, 2002·Journal of Clinical Microbiology·Gaby E PfyfferSabine Rüsch-Gerdes
Jan 25, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y BalabanovaF Drobniewski
Mar 3, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·O S ToungoussovaP Sandven

❮ Previous
Next ❯

Citations

Jan 25, 2012·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Kapil MohanAbhay Nene
Dec 25, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E V KurbatovaJ P Cegielski
Aug 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Chih-Cheng LaiPo-Ren Hsueh
May 22, 2009·The Journal of Antimicrobial Chemotherapy·Manju Y KrishnanMichael T Collins
Jun 15, 2010·The Journal of Antimicrobial Chemotherapy·Kwok Chiu ChangRaphael Chiu Yeung Chan
May 2, 2013·The Journal of Antimicrobial Chemotherapy·T SchönK Angeby
Dec 20, 2007·AIDS·Sarman SinghKrishnamoorthy Gopinath
Jun 7, 2007·Current Opinion in Psychiatry·Antonio Muñoz-Solomando, Richard James Willson Williams
Jun 29, 2011·Antimicrobial Agents and Chemotherapy·Michaela ProjahnStefan Niemann
Dec 12, 2007·Antimicrobial Agents and Chemotherapy·Sung Jae Shin, Michael T Collins
Jan 24, 2007·Antimicrobial Agents and Chemotherapy·Elvira RichterDoris Hillemann
Oct 29, 2008·Antimicrobial Agents and Chemotherapy·Nicole RitzNigel Curtis
Sep 21, 2011·Antimicrobial Agents and Chemotherapy·Silke FeuerriegelStefan Niemann
Jan 12, 2012·PloS One·Robert J GreensteinSheldon T Brown
Jun 8, 2007·Emerging Infectious Diseases·N Sarita ShahJ Peter Cegielski
Oct 25, 2012·Emerging Infectious Diseases·Peter CegielskiMario Raviglione
Apr 30, 2013·Emerging Infectious Diseases·Max R O'DonnellC Robert Horsburgh
Apr 23, 2013·Tuberculosis Research and Treatment·Hyejin KimSungweon Ryoo
Dec 18, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J-Y ChienP-R Hsueh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.